Institut Pasteur Korea

ko en

Excellent phase 2A results
of Q203 * (Telacebec)
presented at WHO
conference and published in AJRCCM

High-throughput screening of
small-molecules libraries identified
antibacterials against clinically
relevant multidrug-resistant
A. baumannii and K. pneumoniae

Awarded the 2025 Excellence in Biosecurity
Management by the Ministry of Trade,
Industry and Resource

Awarded the Ministerial Commendation
from the Ministry of Health and Welfare

Awarded the Gold Prize at the
Integrated R&D Information System (IRIS)
Improvement Idea Contest

Open Lab facility for industry,
academia, and research
institute - Virus Research
Resource Center (RRC)

Mechanism of Q203 (Telacebec)
Gains Spotlight as a Core Strategy
for Tuberculosis Treatment

INSTITUT PASTEUR KOREA AT A GLANCE

From Louis Pasteur of the 19th century to Institut Pasteur Korea of today, we are Pasteurians fighting diseases for everyone in the world

Research & Technology
at a Glance Discovery Biology Translational Research Research Infra Center

Areas of Expertise
Fighting Diseases Fostering Collaboration Education & Training

Our Impact
Research & Technology Service Technology & Infrastructure

Technology for All
Pasteur Network Nobel Laureates Legacy of Louis Pasteur

Pasteurians

Stories to Share

Materials to
Learn More About Us